Van Hese Laura, De Vleeschouwer Steven, Theys Tom, Rex Steffen, Heeren Ron M A, Cuypers Eva
Division of Mass Spectrometry Imaging, Maastricht MultiModal Molecular Imaging (M4I) Institute, Maastricht University, Universiteitssingel 50, 6229 ER, Maastricht, The Netherlands.
Department of Anaesthesiology, University Hospitals Leuven, 3000, Leuven, Belgium.
Discov Oncol. 2022 Nov 10;13(1):123. doi: 10.1007/s12672-022-00585-z.
Brain tumour identification and delineation in a timeframe of seconds would significantly guide and support surgical decisions. Here, treatment is often complicated by the infiltration of gliomas in the surrounding brain parenchyma. Accurate delineation of the invasive margins is essential to increase the extent of resection and to avoid postoperative neurological deficits. Currently, histopathological annotation of brain biopsies and genetic phenotyping still define the first line treatment, where results become only available after surgery. Furthermore, adjuvant techniques to improve intraoperative visualisation of the tumour tissue have been developed and validated. In this review, we focused on the sensitivity and specificity of conventional techniques to characterise the tumour type and margin, specifically fluorescent-guided surgery, neuronavigation and intraoperative imaging as well as on more experimental techniques such as mass spectrometry-based diagnostics, Raman spectrometry and hyperspectral imaging. Based on our findings, all investigated methods had their advantages and limitations, guiding researchers towards the combined use of intraoperative imaging techniques. This can lead to an improved outcome in terms of extent of tumour resection and progression free survival while preserving neurological outcome of the patients.
在数秒内识别和勾勒脑肿瘤将显著指导和支持手术决策。在此,治疗常因胶质瘤浸润周围脑实质而变得复杂。准确勾勒浸润边缘对于扩大切除范围和避免术后神经功能缺损至关重要。目前,脑活检的组织病理学标注和基因表型分析仍是一线治疗的依据,而结果要在手术后才能获得。此外,已开发并验证了辅助技术以改善肿瘤组织的术中可视化。在本综述中,我们重点关注了传统技术在表征肿瘤类型和边缘方面的敏感性和特异性,特别是荧光引导手术、神经导航和术中成像,以及更具实验性的技术,如基于质谱的诊断、拉曼光谱和高光谱成像。基于我们的研究结果,所有研究方法都有其优缺点,这引导研究人员采用术中成像技术的联合使用。这可以在保留患者神经功能结果的同时,在肿瘤切除范围和无进展生存期方面带来更好的结果。